Cargando…

MicroRNA-608 sensitizes non-small cell lung cancer cells to cisplatin by targeting TEAD2

Cisplatin has been widely used as a conventional treatment for patients with non-small cell lung cancer (NSCLC). However, primary and acquired cisplatin resistances are frequently developed during the treatment of patients with NSCLC, leading to an increased mortality rate. Accumulating evidence dem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanli, Li, Fengcai, Ma, Dandan, Gao, Yuhua, Li, Runpu, Gao, Yingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755186/ https://www.ncbi.nlm.nih.gov/pubmed/31485614 http://dx.doi.org/10.3892/mmr.2019.10616

Ejemplares similares

MicroRNA-497-5p negatively regulates the proliferation and cisplatin resistance of non-small cell lung cancer cells by targeting YAP1 and TEAD1
por: Zeng, Shang-Gan, et al.
Publicado: (2019)

Competing targets of microRNA-608 affect anxiety and hypertension
por: Hanin, Geula, et al.
Publicado: (2014)

Competing targets of microRNA-608 affect anxiety and hypertension
por: Hanin, Geula, et al.
Publicado: (2014)

MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4
por: Wang, Yi-Fei, et al.
Publicado: (2019)

Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4
por: Wang, Yi-Fei, et al.
Publicado: (2021)

The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis
por: Dai, Zhi-Ming, et al.
Publicado: (2018)

MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma
por: Li, Maoyuan, et al.
Publicado: (2020)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

MicroRNA-608 and MicroRNA-34a Regulate Chordoma Malignancy by Targeting EGFR, Bcl-xL and MET
por: Zhang, Ying, et al.
Publicado: (2014)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
por: Bian, Hai-Bo, et al.
Publicado: (2011)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway
por: Liang, Zhen, et al.
Publicado: (2017)

microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10
por: Yang, Hongju, et al.
Publicado: (2015)

Inhibitory effect of microRNA-608 on lung cancer cell proliferation, migration, and invasion by targeting BRD4 through the JAK2/STAT3 pathway
por: Xu, Weigang, et al.
Publicado: (2020)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)

Intensified vmPFC surveillance over PTSS under perturbed microRNA-608/AChE interaction
por: Lin, T, et al.
Publicado: (2016)

MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
por: Liang, Wei, et al.
Publicado: (2019)

Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells
por: Huang, Chu, et al.
Publicado: (2020)

MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis
por: Zheng, Jian, et al.
Publicado: (2021)

MicroRNA-29a enhances cisplatin sensitivity in non-small cell lung cancer through the regulation of REV3L
por: Chen, Xialin, et al.
Publicado: (2019)

EEG functional connectivity is sensitive for nitrogen narcosis at 608 kPa
por: Vrijdag, Xavier C. E., et al.
Publicado: (2022)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)

MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
por: Geng, Shuo, et al.
Publicado: (2016)

Knockdown of long non-coding MIR210HG inhibits cell proliferation, migration, and invasion in hepatoblastoma via the microRNA-608–FOXO6 axis
por: Duan, Yuhe, et al.
Publicado: (2021)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein
por: Wei, Xiaoli, et al.
Publicado: (2019)

Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer
por: Chen, Jibing, et al.
Publicado: (2023)

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
por: Ning, Fang-ling, et al.
Publicado: (2014)

microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
por: LI, HAO, et al.
Publicado: (2014)

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
por: Sclafani, Francesco, et al.
Publicado: (2016)

MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
por: LIU, RONGHUA, et al.
Publicado: (2014)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2
por: Li, Li, et al.
Publicado: (2020)

Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
Publicado: (2019)

microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma
por: Wang, Ziyao, et al.
Publicado: (2023)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
por: Rose, Maimon C., et al.
Publicado: (2014)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pp0hefamg12c4ciud76sih5km